UBS Downgrades Option Care Health to Neutral, Lowers Price Target to $32.05
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsDowngradesPrice Target
UBS analyst A.J. Rice downgrades Option Care Health (NASDAQ:OPCH) from Buy to Neutral and lowers the price target from $39 to $32.05.
UBS analyst A.J. Rice downgrades Option Care Health (NASDAQ:OPCH) from Buy to Neutral and lowers the price target from $39 to $32.05.